Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Talis Biomedical Corporation - common stock (NQ:TLIS)

4.380 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Talis Biomedical Corporation - common stock

< Previous 1 2 3 4 5 6 Next >
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
TLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024
Talis Biomedical just reported results for the second quarter of 2024. 
Via InvestorPlace
Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast
 
Via Benzinga
Topics Stocks
Crude Oil Jumps Over 3%; Upstart Shares Spike Higher
 
Via Benzinga
Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates
 
Via Benzinga
Topics Earnings
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
Talis Biomedical just reported results for the first quarter of 2024. 
Via InvestorPlace
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Talis Biomedical just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Why Talis Biomedical (TLIS) Stock Is Getting Obliterated Today
Talis Biomedical shares are trading lower by 49% to $4.58 during Wednesday's session. The company announced board restructuring, appointed new directors and updated investors on potential bankruptcy... 
Via Benzinga
Topics Bankruptcy
Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
Talis Biomedical stock is down on Wednesday as TLIS investors have concerns about board changes and a possible bankruptcy. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
BTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To Know
 
Via Benzinga
A Preview Of Talis Biomedical's Earnings
 
Via Benzinga
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga
Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Talis Biomedical Corp (NASDAQ: TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it is exploring strategic options to boost shareholder value due to 
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter... 
Via Benzinga
Topics Stocks
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
From Talis Biomedical Corporation
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
There’s a time to buy and there’s a time to red flag small-cap stocks to avoid in August before they sink your portfolio. 
Via InvestorPlace
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific 
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
From Talis Biomedical Corporation
Via GlobeNewswire
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
From Talis Biomedical Corporation
Via GlobeNewswire
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical Announces 1-for-15 Reverse Stock Split
From Talis Biomedical Corporation
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.